Trial intelligence / Profile preview

Dose-response, randomized, double-blind exploratory trial of intra-articular DA-5202 in knee osteoarthritis

KCT0001699Phase 2Recruiting

Sponsor
Dong-A ST
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of DA-5202 in osteoarthritis (OA), sponsored by Dong-A ST. Started Dec 2014; status: recruiting.

02

Drugs

DA-5202
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on KCT0001699.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001699.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call